News

Zacks.com on MSN1d

Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?

ISRG's Q2 procedure growth hits 17%, but continuation of EPS growth hinges on easing margin pressure from FX and da Vinci 5 ...

ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts

The Zacks Consensus Estimate for Boston Scientific’s second-quarter 2025 adjusted earnings per share (EPS) is currently ...